IL2 and autoimmune thyroid disease: The IL-2 targeted SPECT radiotracers, [99mTc]IL-2 and [99mTc]HYNIC-IL-2, have already been applied successfully for the visualization of vulnerable atherosclerotic plaques, transplant rejection and autoimmune thyroid disease (74–76).